<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were enrolled at the Samsung Medical Center between November 13, 2014 and November 19, 2015. Inclusion criteria for preterm infants included gestational age of 23–34 weeks, and diagnosis with severe IVH (≥grade 3 by Papile's classification 
 <xref rid="sct312351-bib-0024" ref-type="ref">24</xref>) using cranial ultrasonography assessed independently by two radiologists. Transplantation of MSCs was performed within 7 days after the first diagnosis of severe IVH (≥grade 3). Patients were excluded for severe congenital anomalies, antenatal brain hemorrhage, intracranial infection, congenital infection, uncorrected thrombocytopenia (&lt;50,000/ml), uncorrected severe metabolic acidosis (pH &lt;7.1), surgery within 72 hours prior to intended enrollment, expectation of surgery or death within several days after enrollment, or enrollment in another clinical trial.
</p>
